Market Overview

UPDATE: Goldman Sachs Upgrades Agilent Technologies to Buy on Valuation, End Market Outlook

Related A
Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest Dividend Yield
Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving

Goldman Sachs raised its rating on Agilent Technologies (NYSE: A) from Neutral to Buy with a $49 price target.

Goldman Sachs noted, "After underperforming the S&P 500 by 560bp YTD, we see an attractive risk/reward profile, strong ROIC, and attractive valuation coupled with the following catalysts: (1) trends in EM are improving and Agilent has group-leading exposure, (2) accelerating wireless capex should benefit the Electronic Measurement Group's (EMG) business, (3) Agilent should continue to gain share and improve margins in Life Sciences Group (LSG), and (4) lower expectations now create a hospitable environment for multiple expansion. Lastly, we note that Agilent is a member of the GS Sustain List and was recently featured as a leader in Healthcare on ESG, IP, and ROIC based metrics."

Agilent Technologies closed at $35.81 on Friday.

Latest Ratings for A

DateFirmActionFromTo
Sep 2014Morgan StanleyInitiates Coverage onEqualweight
May 2014Bank of AmericaMaintainsBuy
May 2014JefferiesMaintainsBuy

View More Analyst Ratings for A
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (A)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters